https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-442001-09-01 00:00:002019-02-15 08:47:02Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-05-01 / J. Neurooncol. 2001 May;53(1):39-46
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-05-01 / J. Neurooncol. 2001 May;53(1):39-462001-05-01 00:00:002001-05-01 00:00:00Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-02-01 / Cancer Res. 2001 Feb;61(3):842-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-02-01 / Cancer Res. 2001 Feb;61(3):842-72001-02-01 00:00:002019-02-15 08:47:03Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-12-15 / Neurosurg Focus 2000 Dec;9(6):e8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-12-15 / Neurosurg Focus 2000 Dec;9(6):e82000-12-15 00:00:002019-02-15 08:46:54Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-05-05 / JAMA 1999 May;281(17):1588-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-05-05 / JAMA 1999 May;281(17):1588-91999-05-05 00:00:002019-02-15 09:00:19Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1995-10-01 / Strahlenther Onkol 1995 Oct;171(10):560-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1995-10-01 / Strahlenther Onkol 1995 Oct;171(10):560-721995-10-01 00:00:001995-10-01 00:00:00Hyperthermia–its actual role in radiation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1992-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 1992;24(4):657-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1992-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 1992;24(4):657-671992-01-01 00:00:001992-01-01 00:00:00Treatment of malignant gliomas with interstitial irradiation and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1988-04-01 / Gan To Kagaku Ryoho 1988 Apr;15(4 Pt 2-2):1370-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1988-04-01 / Gan To Kagaku Ryoho 1988 Apr;15(4 Pt 2-2):1370-51988-04-01 00:00:001988-04-01 00:00:00[Radiofrequency hyperthermia in malignant brain tumors: clinical trials]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1987-05-29 / Wien. Klin. Wochenschr. 1987 May;99(11):393-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1987-05-29 / Wien. Klin. Wochenschr. 1987 May;99(11):393-71987-05-29 00:00:001987-05-29 00:00:00[Local hyperthermia of malignant brain tumors]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1984-01-01 / J. Neurooncol. 1984;2(1):19-28
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1984-01-01 / J. Neurooncol. 1984;2(1):19-281984-01-01 00:00:001984-01-01 00:00:00Combination radiofrequency hyperthermia and chemotherapy (BCNU) for brain malignancy. Animal experience and two case reports
